A Nonradioactive Iothalamate Method for Measuring Glomerular Filtration Rate and Its Use to Study the Renal Handling of Cibenzoline
- 30 November 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 10 (4) , 434-437
- https://doi.org/10.1097/00007691-198804000-00010
Abstract
A simple, sensitive, and highly reliable liquid chromatographic method using fluorescence detection is described for the simultaneous determination of metoprolol and α-hydroxymetoprolol in plasma and urine. This method involves a single extraction of the compounds with the internal standard pindolol from alkalinized plasma or urine into dichloromethane. A reconstituted aliquot with a mobile phase is injected onto a reversed-phase, Zorbax ODS column, and the detection is achieved by the excitation and emission wavelengths at 230 and 300 nm, respectively. The assay is reproducible and precise for metoprolol and α-hydroxymetoprolol in both plasma and urine samples, as judged by a coefficient of variation of <9.2% at all concentrations examined. The standard curves for metoprolol and α-hydroxymetoprolol are linear over 10–200 ng/ml in plasma and over 0.5–10 mUg/ml in urine. The lower detection limit is 2 ng/ml for each of the compounds in plasma using a 0.5-ml sample. Preliminary data on the oxidation polymorphism of metoprolol in Japanese subjects are reported using the current assay method. In 183 Japanese subjects no poor metabolizer of metoprolol has been identified so far.Keywords
This publication has 4 references indexed in Scilit:
- Age and cibenzoline dispositionClinical Pharmacology & Therapeutics, 1984
- Determination of cibenzoline in plasma and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- The Effect of Cimetidine, a New Histamine H2‐Receptor Antagonist, on Renal FunctionActa Medica Scandinavica, 1979
- 125I-Iothalamate and Creatinine Clearances in Patients with Chronic Renal DiseaseNephron, 1979